[Federal Register Volume 86, Number 84 (Tuesday, May 4, 2021)]
[Notices]
[Pages 23740-23741]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09301]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-830]


Bulk Manufacturer of Controlled Substances Application: Cargill, 
Incorporated

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Cargill, Inc., has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before July 6, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before July 6, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on March 31, 2021, Cargill, Incorporated, 17540 Monroe 
Wapello Road, Eddyville, Iowa 52553, applied to be registered as a bulk 
manufacturer of the following basic class(es) of controlled 
substance(s):

[[Page 23741]]



------------------------------------------------------------------------
                                                        Drug
                Controlled substance                    code    Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid...........................     2010          I
------------------------------------------------------------------------

    The company plans to bulk manufacture butanediol as a raw material 
for industrial and consumer products. Gamma Hydroxybutyric Acid will be 
manufactured as a byproduct and an impurity waste of butanediol. The 
company does not plan to bulk manufacture this drug. No other 
activities for this drug code are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-09301 Filed 5-3-21; 8:45 am]
BILLING CODE P